Image
Back to top
Prof Lluís Puig
Director of Dermatology
Professor Lluís Puig is Director of Dermatology at the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, and Professor of Dermatology at the University of Barcelona, Spain.
For over 15 years, Professor Puig’s clinical research has focused on the treatment of psoriasis with biological agents. He has worked on over 85 clinical trials and research projects, primarily as the principal investigator.
Professor Puig also serves on several editorial boards and has published over 300 papers in journals such as The New England Journal of Medicine, Journal of the European Academy of Dermatology and Venereology, and British Journal of Dermatology.
He is a member of multiple national and international scientific societies, has been a member of the board of directors of the European Academy of Dermatology and Venereology (EADV), and is co-Chair of the Psoriasis Task Force of the EADV, Member of the GRAPPA Education and Steering Committees, and Board Member of the International Psoriasis Council.
0 resources
You are currently seeing only Dermatology content
File672 KB size
The first part of the workshop highlights the role of shared decision-making for personalised care in women of childbearing age affected by psoriasis and PsA....
File633 KB size
The workshop highlights the challenges and treatment considerations with psoriasis and HS that go beyond the skin. Underlying disease pathophysiology, including...
Video51 min watch
The speakers discuss the continued unmet needs of patients with inflammatory diseases of skin and joints in terms of treatment outcomes and health-related...
Video59 min watch
This session reviews the chronic inflammation and pathophysiology of HS, highlighting the association between patients with inflammatory arthritis and HS. The...
Video61 min watch
This session focuses on the pathobiological relationship between psoriasis and psoriatic arthritis (PsA), how transition from psoriasis to PsA occurs, as well as...
Video68 min watch
In this session, our speakers explore the inflammatory pathways in immune-mediated inflammatory disease in the context of the evolving treatment considerations...